Vetanco International Acknowledgment for Sherry Layton, Vetanco Scientific Director

Sherry Layton, Vetanco Scientific Director, will be awarded in the 12th International Conference on Emerging Infectious Diseases

Diretora de Biotecnologia da Vetanco/BV Science no European Animal Microbiome Congress – O Presente Rural

Frontiers Differential Effects of Bacitracin Methylene Disalicylate (BMD) on the Distal Colon and Cecal Microbiota of Young Broiler Chickens

Emerging Diseases 2021, Emerging Infectious Diseases Conferences in 2021, Infectious Disease Conferences 2021, Emerging Infectious Diseases Conferences 2021, Rare Diseases 2021 Conferences, Europe, USA

PDF) Immunomodulatory Effects of Saccharomyces cerevisiae Fermentation Product Supplementation on Immune Gene Expression and Lymphocyte Distribution in Immune Organs in Broilers

Sherry Layton - Chief Executive Officer - Vetanco USA

New Trends in Vaccine Development

PDF) Development and evaluation of candidate recombinant Salmonella-vectored Salmonella vaccines

Vaccines Conference-2022, Global Conference on Vaccines Research and Development

Vaccines Conference-2022, Global Conference on Vaccines Research and Development

PDF) Strategies for Enhancing the Effectiveness of Metagenomic-based Enzyme Discovery in Lignocellulolytic Microbial Communities

Sherry Layton - Chief Executive Officer - Vetanco USA

Vaccines Conference-2022, Global Conference on Vaccines Research and Development